Ozempic Blindness Lawsuits: Legal Claims Allege GLP-1 Drugs Linked to NAION Vision Loss

Start
Glucagon-like peptide-1 receptor agonist drugs (commonly referred to as GLP-1 agonists) have become widely prescribed for type 2 diabetes and weight loss. Medications such as Ozempic, Wegovy, Mounjaro, and other GLP-1 drugs have been promoted for their effectiveness in controlling blood sugar and supporting weight reduction….
By: Hissey, Mulderig & Friend, PLLC
Previous Story

AI Chatbots Face Rising Legal and Legislative Scrutiny

Next Story

Preserving the Attorney-Client Privilege in Third-Party Liability Claims: What Captive Groups Need to Know